World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 8 February 2021
Main ID:  NCT00866983
Date of registration: 20/03/2009
Prospective Registration: No
Primary sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Public title: Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Scientific title: A Local, Multi-Centre, Extension, Open Label Access Study, To Provide Sildenafil Therapy For Patients Who Completed A1481244 Study And Are Judged By The Investigator To Derive Clinical Benefit From Continued Treatment With Sildenafil , Prior To Reimbursement And Availability For Patients In Brazil.
Date of first enrolment: October 2008
Target sample size:
Recruitment status: No longer available
URL:  https://clinicaltrials.gov/show/NCT00866983
Study type:  Expanded Access
Study design:   
Phase: 
Countries of recruitment
Brazil
Contacts
Name:     Pfizer CT.gov Call Center
Address: 
Telephone:
Email:
Affiliation:  Pfizer
Key inclusion & exclusion criteria

Inclusion Criteria:

- Subject who completed the A1481244 study and are judged by the Investigator to derive
clinical benefit from continuous treatment with Sildenafil 20 mg therapy.

- Subject who resides in a Brazilian State where Sildenafil is not supplied by State
Health Secretary.

Exclusion Criteria:

- Pregnant or lactating women.

- Current participation in other studies and during study participation.



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Pulmonary Arterial Hypertension
Intervention(s)
Drug: sildenafil (Revatio) 20 mg TID
Primary Outcome(s)
Secondary Outcome(s)
Secondary ID(s)
A1481270
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history